Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSummaries for patients. The cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for patients with diabetes.SubjectsUNITED States; CARDIOVASCULAR disease prevention; ECONOMIC impact; MEDICARE; TYPE 2 diabetes complications; ACE inhibitors; COST effectiveness; DIABETIC angiopathies; DIABETIC nephropathies; TYPE 1 diabetes; MEDICAL care costs; PROBABILITY theory; DISEASE complicationsPublicationAnnals of Internal Medicine, 2005, Vol 143, Issue 2, pI21ISSN0003-4819Publication typejournal articleDOI10.7326/0003-4819-143-2-200507190-00002